Diasorin | DIA - Cost Of Sales

Stock Price
71.20
Daily Change
1.38 1.98%
Monthly
-0.86%
Yearly
-29.82%
Q1 Forecast
68.08

Diasorin reported EUR99.64M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Amplifon EUR 460.17M 14.78M Sep/2025
Avanos Medical USD 94.9M 3.1M Dec/2025
Brookdale Senior Living USD 602.31M 42.07M Sep/2025
Cencora USD 80.77B 3.02B Sep/2025
Diasorin EUR 99.64M 4.71M Sep/2025
Encompass Health USD 150.9M 3.9M Dec/2025
Enovis USD 271.52M 7.83M Dec/2025
GE HealthCare Technologies USD 3.15B 131M Sep/2025
OPKO Health USD 104.78M 32.97M Sep/2025
Veradigm USD 68.49M 2.93M Sep/2022
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025